Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

Safety, Pharmacokinetics and Pharmacodynamics of BKM120 Plus MEK162 in Selected Advanced Solid Tumor Patients

Array Biopharma, now a wholly owned subsidiary of Pfizer · 2011
ClinicalTrials.gov · Datasets · License: Public Domain · 2011
Open Source ↗
ovarian-cancerpancreatic-cancertriple-negative-breast-cancer
advanced solid tumors, selected solid tumors, bkm120, mek162, ras raf mutations, triple negative breast cancer, pancreatic cancer, ovarian cancer, nsclc progressed on egfr tki, pi3k inhibitor, mek inhibitor, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1032968
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.